TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal Cord Injury

Improve Dynamic Lateral Balance of Humans With SCI

Eligible age

18–65 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is to test whether pelvis perturbation training paired with transcutaneous spinal direct current stimulation (tsDCS) will be effective in improving dynamic balance and locomotor function in humans with SCI. One group will receive pelvis perturbation training paired with tsDCS, one group will receive pelvis perturbation training paired with sham, and one group will receive treadmill training only.

Sponsor: Shirley Ryan AbilityLab

You may qualify if…

  • 1. age between 18 and 65 years;
  • 2. medically stable with medical clearance to participate;
  • 3. level of the SCI lesion between C4-T10;
  • 4. passive range of motion of the legs within functional limits of ambulation;
  • 5. ability to walk on a treadmill for more than 20 minutes with partial body weight support as needed and short sitting/standing breaks;
  • 6. ability to ambulate without orthotics or with orthotics that do not cross the knee for more than 10 meters

You may not qualify if…

  • 1. the presence of unhealed decubiti, existing infection, severe cardiovascular and pulmonary disease, concomitant central or peripheral neurological injury (e.g. traumatic head injury or peripheral nerve damage in lower limbs);
  • 2. history of recurrent fractures and/or known orthopedic injury to the lower extremities;
  • 3. Botox injection within 6 months of starting the study, and current receiving physical therapy treatment;
  • 4. have metallic implantation in the spinal region underneath where electrodes may be placed.

Where it's recruiting

Illinois

Chicago

Source: ClinicalTrials.gov · NCT02991248 · last updated 2025-06-03

Improve Dynamic Lateral Balance of Humans With SCI · TrialPath